Kidney RSS News Feeds

Nephrology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Fishbane S et al. - A variety of factors have been identified that increase the risk of posttransplant anemia, of which the level of renal function is most important. Sirolimus, a mammalian target of rapamycin inhibitor, has been implicated as playing a special role in posttransplant anemia. This review considers anemia associated with sirolimus, including its presentation, mechanisms, and management.


Today in Hematology/Oncology...keeping you current

Pseudopheochromocytoma: An uncommon cause of malignant hypertension
Indian Journal of Nephrology, 10/16/09

Upfront, randomized, phase II trial of sorafenib versus sorafenib and low-dose interferon alfa in patients with advanced renal cell carcinoma
Cancer, 11/03/09

New treatment approaches in renal cell carcinoma
Anti-Cancer Drugs, 10/15/09

Today in Pharmacology/kinetics...keeping you current

Interventions for HIV-associated nephropathy
Cochrane Reviews, 10/19/09

Drug dosage protocol for calcium oxalate stone
Urological Research - Urolithiasis, 10/23/09

Comparison of Gentamicin and Mupirocin in the Prevention of Exit-Site Infection and Peritonitis in Peritoneal Dialysis
Advances in Peritoneal Dialysis, 10/20/09

Today in Transplantation...keeping you current

Significance and Management of Proteinuria in Kidney Transplant Recipients
Journal of the American Society of Nephrology, 10/12/09

KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary
Kidney International, 10/27/09

Incidence and predictors of osteonecrosis among cyclosporin- or tacrolimus-treated renal allograft recipients
Rheumatology International, 11/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address